UltraShape received CE mark approval in June 2005 for the Contour I system, the first non-invasive ultrasound device for body contouring. 

Yoram Eshel, PhD, CEO of UltraShape, said: “With over 15 years of successful sales and marketing experience in aesthetic medical devices, Bob is the ideal person to lead our United States operations. He has proven experience in launching new technologies, creating new markets and developing and leading high performance sales organizations” said Eshel. 

“UltraShape is an exciting company with a proprietary technology supported by sound science and extensive research. Our unique product offering meets a significant and currently unmet physician and patient need for non-invasive body contouring. I look forward to being part of the UltraShape senior management team and leading the company’s operations in the United States,” said Robert Gerberich. 

Prior to joining UltraShape, Mr. Gerberich served as the Vice President of Marketing and Sales and Vice President of Sales at Thermage Inc. Mr. Gerberich was responsible for launching a non-invasive tissue tightening technology and led the effort in building sales to $50 million.. Prior to Thermage, he led the sales force at INAMED Aesthetics (formally McGhan Medical) to achieve market leadership position in the distribution of specialty products to plastic surgeons, dermatologists, and other physician specializing in cosmetic and reconstructive procedures. Before Inamed, he was part of a core management team responsible for launching LySonix Inc. and its unique technology for ultrasonic assisted liposuction. Mr. Gerberich holds a Bachelor of Science from Illinois State University, IL.

About UltraShape:

UltraShape is redefining aesthetic medicine by developing, manufacturing, and marketing innovative non-invasive devices for body contouring. The Company is dedicated to providing healthcare professionals with leading edge solutions that enhance the lives of patients worldwide. The UltraShape proprietary technology is based on focused ultrasound waves that selectively disrupt adipose (fat) cells without affecting surrounding tissues. The safety and effectiveness of the UltraShape surgery-free solution has been clinically proven in hundreds of patients. The Company’s products are marketed in over 20 countries. UltraShape Ltd. is a privately held company founded in 2000. For more information visit www.ultrashape.com.